chief operating officer

launch button

Pharma

IntraBio hits the ground running with new rare disease launch

With its first approval in hand, privately held IntraBio is embarking upon the difficult task of marketing a drug for an ultra-rare disease.

Fraiser Kansteiner Sep 30, 2024 3:25pm

Argenx

Argenx isn't sweating over Vyvgart competitors: exec

May 9, 2024 4:56pm